Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Deep brain stimulation (DBS) is a well-established approach for treating movement disorders such as Parkinson disease, dystonia and essential tremor. However, the outcomes are variable, and researchers are now exploring artificial intelligence-based strategies to help improve DBS procedures.
The overarching theme of the ninth Congress of the European Academy of Neurology (1–4 July 2023) is ‘neurology beyond big data’. The Congress provides an opportunity for neurologists, neuroscientists and other experts to discuss how the power of neurological data might be harnessed to advance discovery and improve patient outcomes and brain health.
Digital technologies for data collection and remote monitoring can offer several indubitable advantages in neurological disorders. However, an equitable future for the use of digital technology in neurology will be possible only with global, collaborative and multidisciplinary planning that should be promptly prepared and implemented.
Researchers in China have developed a functional nucleic acid-based responsive artificial enzyme that enables continuous production of levodopa in a mouse model of Parkinson disease.
A new study indicates loss of hypothalamic melanin-concentrating hormone in ALS, providing insights into the mechanisms underlying weight loss in individuals with the disease.
A new study provides mechanistic insights into the role of TDP43 in regulating the expression of stathmin 2 — a protein that is abundant in motor neurons and is required for axonal regeneration after injury.
According to new research in a mouse model, systemic immune exhaustion could underlie the association between obesity and risk of developing Alzheimer disease.